# TEPEZZA

NDC: 75987-130
Generic name: teprotumumab
Labeler / Manufacturer: Horizon Therapeutics USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200121

FDA application: BLA761143

## Active ingredients

- TEPROTUMUMAB: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75987-130"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75987-130
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e6c54a1-cefd-4a5b-a855-ab9f268b6cce